YK11 stands out as a mighty SARM, working as a
partial agonist of the androgen receptor (AR) by
targeting specific genes, such as myostatin
(GDF8), by increasing the synthesis of follistatin
(FST), enhancing its potential in promoting
muscle growth and bone tissue development.
